Skip to main content
. 2011 Sep 19;8:33. doi: 10.1186/1742-4682-8-33

Figure 13.

Figure 13

Cross-model validation to experiments of endogenous opioid production concerning the population dynamics of Pseudomonas agents and endogenous flora. The competitive advantage of the Pseudomonas agents is due to the suppression of commensal bacteria resulting from the Pseudomonas agents' activation of virulence factors and production of HQNO (which inhibits commensal bacterial growth) (information extracted from Additional File 6).